Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

The Carlyle Group continues to execute its pre-arranged stock sale plan in QuidelOrtho Corp, disposing of shares at weighted average prices ranging from approximately $32.71 to $33.80.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of additional shares.
• These transactions occurred on June 27 and June 28, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2024.
• On June 27, 2024, 46,380 shares of common stock were sold at a weighted average price of $33.5144, with prices ranging from $33.07 to $33.80.
• On June 28, 2024, two transactions occurred: 18,795 shares were sold at a weighted average price of $32.8281 (ranging from $32.71 to $32.9995), and 31,142 shares were sold at a weighted average price of $33.1786 (ranging from $33.00 to $33.56).
• Following these transactions, the Carlyle Group's indirect beneficial ownership stands at 11,520,751 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• Several entities within the Carlyle Group structure may be deemed to share beneficial ownership but disclaim it.

Sentiment

Score: 5

Explanation: The document is neutral. It simply reports transactions. The impact on sentiment depends on how investors interpret the Carlyle Group's ongoing share sales.

Positives

• The sales are being conducted under a pre-arranged 10b5-1 trading plan, which provides transparency and reduces the risk of insider trading allegations.

Negatives

• The Carlyle Group is reducing its stake in QuidelOrtho, which could be interpreted negatively by the market.

Risks

• Continued sales by the Carlyle Group could put downward pressure on QuidelOrtho's stock price.
• Market perception of the Carlyle Group's reduced stake could negatively impact investor confidence.

Future Outlook

The document does not provide specific forward-looking statements, but it indicates that the Carlyle Group will likely continue selling shares under the existing 10b5-1 trading plan.

Industry Context

Share sales by major shareholders are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The impact on QuidelOrtho's stock price will depend on market conditions and investor sentiment.

Stakeholder Impact

• Shareholders may be concerned about the potential downward pressure on the stock price due to the Carlyle Group's sales.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal unless the share sales significantly impact the company's financial stability.

Key Dates